5 Min Read
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s)
NOTE: Reuters is converting some short-form coverage of hot stocks, including Market Pulse, into the new Stocks Buzz product. From June 16, items that were previously published only as a compilation will be published as standalone items featuring the BUZZ tag. They will also be accessible via the STXBZ news code. A collated version will continue to appear on the WATCH/US named-item code under the headline "BUZZ-U.S. stocks on the move".
Dow Jones industrial average futures were down 0.18 percent at 16,720, S&P 500 futures were down 0.16 percent at 1,927.5 and Nasdaq 100 futures were down 0.07 percent at 3,768.5.
** TWITTER INC, Thursday close $36.79
The micro blogging website on Thursday announced the abrupt departure of two senior executives, including the chief operating officer who had been responsible for the social media company's efforts to revive flagging user growth.
** INTEL CORP, Thursday close $27.96, +5.51 pct premarket
The chipmaker on Thursday raised its outlook for the second quarter and the full year, citing stronger-than-expected demand for personal computers used by businesses.
** TESLA MOTORS INC, Thursday close $203.52, -0.01 pct premarket
The company on Thursday said it would allow others to use its intellectual property in hopes of speeding up development of electric cars by all manufacturers.
** AT&T INC, Thursday close $34.83
** DIRECTV, Thursday close $82.92
The U.S. Senate Judiciary Committee's antitrust panel will hold a hearing on June 24 to examine the proposed purchase by AT&T of DirectTV, the committee said on Thursday.
** APOLLO GLOBAL MANAGEMENT LLC, Thursday close $27.35
The private equity firm is in talks to buy Encana Corp's Bighorn Properties in Alberta, Canada in a deal expected to be worth about $1.8 billion, the Wall Street Journal reported.
** LIBERTY GLOBAL PLC, Thursday close $43.26
** DISCOVERY COMMUNICATIONS INC, Thursday close $78.5
John Malone's Liberty Global and Discovery Communications are in discussions with the owners of Formula One to bridge a $1 billion gap in the valuation of the motor-racing series as they seek to buy a 49 percent stake, according to Bloomberg.
** FINISAR CORP, Thursday close $25.25, -21.82 pct premarket
The maker of fiber optic components used in network communication equipment, forecast current-quarter profit well below expectations, citing higher capital expenditures in China.
** EXPRESS INC, Thursday close $13.55, +23.39 pct premarket
Private equity firm Sycamore Partners on Thursday said it was interested in acquiring apparel retailer Express, after disclosing a 9.9 percent stake that made it the largest shareholder in the company.
** CBS CORP, Thursday close $60.88
** TIME WARNER INC, Thursday close $68.37
The owner of Univision Communications Inc have recently held preliminary talks about selling the Spanish-language broadcaster with CBS, Time Warner and other media companies, the Wall Street Journal reported, citing people familiar with the matter.
** SALIX PHARMACEUTICALS LTD, Thursday close $113.8
** CUBIST PHARMACEUTICALS INC, Thursday close $69.41
** ASTRAZENECA PLC, Thursday close $74.04, -0.03 pct premarket
** NEKTAR THERAPEUTICS, Thursday close $12.54
** PROGENICS PHARMACEUTICALS INC, Thursday close $4.2161, +6.02 pct premarket
An advisory committee to the U.S. Food and Drug Administration recommended on Thursday that the agency not require large cardiovascular safety trials for a class of drugs used to treat opioid-induced chronic constipation.
Seven panelists voted in favor of such trials, five voted in favor for select products and 12 voted against. But in a post-vote discussion, several panelists said they misunderstood the question and would have voted against the requirement.
The drugs, known as peripherally acting mu opioid receptor antagonists, include Progenics's Relistor, which has been licensed to Salix and Cubist's Entereg. AstraZeneca and Nektar also have a product, naloxegol, in development.
** ALLERGAN INC, Thursday close $162.04
William Ackman's Pershing Square Capital Management said it had filed a lawsuit seeking confirmation that a requested special shareholder meeting of Allergan's shareholders would not trigger Allergan's poison pill takeover defense.
** SUNEDISON INC, Thursday close $19.28
The solar company said it signed a deal with NEXTracker Inc for the purchase of up to 1.85 gigawatts of trackers for the company's ground-mounted projects over the next three years. (Reporting By Shubhankar Chakravorty in Bangalore)